Skip to content

H.R. 5429 · 118th Congress (2023–2025)

Medication Affordability and Patent Integrity Act

To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.

CRS summary not yet available.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 5429’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Ann M. Kuster (D-NH-2)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Rep. Diana Harshbarger (R-TN-1)· Original · Sep 13, 2023
Policy area
Commerce
Subjects
  • Drug safety, medical device, and laboratory regulation
  • Inflation and prices
  • Intellectual property
  • Manufacturing
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Sep 13, 2023 – Sep 15, 2023
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Sep 13, 2023
  2. HouseHealthReferred Sep 15, 2023
  3. HouseJudiciaryReferred Sep 13, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Medication Affordability and Patent Integrity Act

    Display title, Short title · Introduced in House

  2. To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.

    Official title · Introduced in House